Novoron

NovaGo Therapeutics

This clinical-stage biotechnology company develops human antibody therapeutics to promote nerve regeneration for patients with spinal cord injuries and strokes.

Asceneuron

The company develops oral small molecule therapies for neurodegenerative diseases including Alzheimer's and Parkinson's to treat patients suffering from chronic neurologic disorders.

Neuroplast

This company develops autologous stem cell therapies to treat patients with neurodegenerative diseases including spinal cord injuries and amyotrophic lateral sclerosis.

PharmatrophiX

The company develops small-molecule therapies targeting neurotrophin receptors for patients with Alzheimer's disease and other neurodegenerative disorders.

BE Therapeutics

This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Nuuron

This neurotech company develops a digital neuromodulation therapy delivered through virtual reality headsets to treat patients with Alzheimer's disease.

Reservoir Neuroscience

The company develops therapeutics to repair the blood-brain barrier for patients with age-related neurodegeneration and chronic epilepsy.